NCT05843500View on ClinicalTrials.gov

Chronic Thromboembolic Disease Registry

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2028

Conditions
Chronic Thromboembolic Pulmonary HypertensionChronic Thromboembolic Disease
Interventions
OTHER

Survey

Patients who received medical, surgical or interventional treatment for chronic thromboembolic pulmonary hypertension will be followed and given quality of life questionnaires.

Trial Locations (1)

94143

RECRUITING

University of California San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER